Nontuberculous Mycobacterial Lung Disease (NTM-LD): Individualizing Treatment Goals and Strategies – An Innovative Whiteboard View

FACULTY

Charles L. Daley, MD
Chief, Division of Mycobacterial and Respiratory Infections
Professor of Medicine
National Jewish Health
Denver, CO

Shannon H. Kasperbauer, MD
Associate Professor of Medicine
Department of Medicine
Division of Mycobacterial and Respiratory Infections
National Jewish Health
Denver, CO

PROGRAM OVERVIEW

This online activity will explore the management of patients with nontuberculous mycobacterial lung disease (NTM-LD), including diagnosis, therapy selection, and strategies for assessing and treating patients with refractory disease.


TARGET AUDIENCE

This educational activity is designed to meet the educational needs of pulmonologists and infectious disease specialists involved in the management of patients with NTM-LD.


LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Utilize evidence-based clinical, radiographic, and microbiologic criteria in the evaluation and diagnosis of NTM-LD
  • Develop individualized treatment goals centered on patient health status, comorbidities, and preferences
  • Select therapy for patients with NTM-LD utilizing clinical guidelines and up-to-date evidence
  • Employ evidence-based strategies for enhancing patient tolerance, adherence, and therapy completion in patients with NTM-LD

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


CREDIT DESIGNATION STATEMENT

Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.


CNE ACCREDITATION STATEMENT

Ultimate Medical Academy/Complete Conference Management (CCM) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.


NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the management of patients with NTM-LD.
Credits: 1.0 ANCC Contact Hour.


DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.


DISCLOSURE OF CONFLICTS OF INTEREST

Charles Daley, MD reports the following disclosures:

Relationship Manufacturer
Consultant/Advisor AN2, Insmed
Advisory Board AN2, Insmed, Matinas, Paratek, Spero Therapeutics
Industry/Investigator Initiated Research Beyond Air, BugWorks, Insmed, Paratek, Spero Therapeutics

Shannon Kasperbauer, MD is a speaker for AN2 Pharmaceuticals, Insmed and Paratek, and serves as a consultant for AN2 Pharmaceuticals, Insmed and Paratek.

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

Staff, Planners, and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Felecia Beachum, Program Manager for Med Learning Group, has nothing to disclose.
Diana Tommasi, PharmD, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Russie Allen, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.


DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.


METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this online activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the online activity.
  3. Submit the evaluation form to Med Learning Group.

You will receive your certification as a downloadable file.


DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making skills before applying any information, whether provided here or by others, for any professional use.

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

RELEASE DATE: June 3, 2021

EXPIRATION DATE: June 3, 2022

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

Copyright © 2021 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.